FDA Approved: FAMOTIDINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved the original ANDA for famotidine from Ascend Laboratories, LLC, enabling a generic version of the H2 blocker to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)